Prednisone is evaluated in numerous clinical trials spanning Early Phase 1 through Phase 4, reflecting its broad therapeutic utility as an immunosuppressive and anti-inflammatory corticosteroid. Encompassing active, recruiting, completed, and uninitiated statuses, these studies target conditions ranging from autoimmune disorders and hematologic malignancies to cancer-related immune events. Research sponsors include academic medical centers, university hospitals, and cooperative research networks such as the National Cancer Institute and the Children's Oncology Group.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07220187 | NOT_YET_RECRUITING | Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma; Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma |
SWOG Cancer Research Network |
2026-08-31 | PHASE3 |
| NCT07072585 | NOT_YET_RECRUITING | Stage II T Lymphoblastic Leukemia/Lymphoma; Stage III T Lymphoblastic Leukemia/Lymphoma; Stage IV T Lymphoblastic Leukemia/Lymphoma; T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
Children's Oncology Group |
2026-08-28 | PHASE2; PHASE3 |
| NCT06947967 | RECRUITING | Lymphoma, T-Cell, Peripheral |
Chipscreen Biosciences, Ltd. |
2025-08-12 | PHASE3 |
| NCT05283720 | ACTIVE_NOT_RECRUITING | Non-Hodgkin Lymphoma |
Genmab |
2022-06-14 | PHASE2 |
| NCT07662928 | NOT_YET_RECRUITING | Adult Burkitt Lymphoma |
AIDS Malignancy Consortium |
2026-09-17 | PHASE2 |
| NCT05675410 | RECRUITING | Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 |
National Cancer Institute (NCI) |
2023-05-11 | PHASE3 |
| NCT07715734 | NOT_YET_RECRUITING | Kidney Transplant Recipient; Cutaneous Squamous Cell Carcinoma (CSCC); Advanced Cutaneous Squamous Cell Carcinoma; Kidney Transplant |
Washington University School of Medicine |
2026-09-30 | PHASE2 |
| NCT05605899 | ACTIVE_NOT_RECRUITING | High-risk Large B-cell Lymphoma (LBCL) |
Kite, A Gilead Company |
2023-02-10 | PHASE3 |
| NCT07365995 | RECRUITING | Metastatic Castration-resistant Prostate Cancer |
BioNTech SE |
2026-04-22 | PHASE3 |
| NCT07712588 | NOT_YET_RECRUITING | Diffuse Large B-Cell Lymphoma (DLBCL) |
Dizal Pharmaceuticals |
2026-09 | PHASE2; PHASE3 |
| NCT07431060 | RECRUITING | Langerhans Cell Histiocytosis (LCH) |
West China Second University Hospital |
2026-02-13 | |
| NCT07650240 | NOT_YET_RECRUITING | Recurrent Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8; Castration-Sensitive Prostate Cancer; Metastatic Hormone-sensitive Prostate Cancer (mHSPC); Prostate Cancer; Prostate Adenocarcinoma; Adenocarcinoma of the Prostate; Localized Prostate Carcinoma; Metastatic Prostate Cancer; Metastatic Prostate Adenocarcinoma; Advanced Prostate Cancer; Advanced Prostate Adenocarcinoma |
Mayo Clinic |
2026-07-01 | PHASE2 |
| NCT07719855 | NOT_YET_RECRUITING | Follicular Lymphoma ( FL) |
Ruijin Hospital |
2026-07 | PHASE3 |
| NCT03847649 | RECRUITING | Cancer |
Canadian Cancer Trials Group |
2020-03-09 | PHASE2 |
| NCT06564038 | RECRUITING | Chronic Lymphocytic Leukaemia; Small Lymphocytic Lymphoma; Mantle-cell Lymphoma; Large B-cell Lymphoma; B-cell Non-Hodgkin Lymphoma |
AstraZeneca |
2025-01-30 | PHASE1; PHASE2 |
| NCT04729114 | RECRUITING | Prostate Cancer; Metastatic Castration Resistant Prostate Cancer; Metastatic Castration-sensitive Prostate Cancer |
Astellas Pharma Global Development, Inc. |
2021-06-14 | PHASE1 |
| NCT05848765 | RECRUITING | Relapsed Follicular Lymphoma; Refractory Follicular Lymphoma |
University of Birmingham |
2023-09-04 | PHASE2 |
| NCT05406401 | ACTIVE_NOT_RECRUITING | Lymphoma, Large B-Cell, Diffuse (DLBCL) |
Merck Sharp & Dohme LLC |
2022-07-14 | PHASE2 |
| NCT06072768 | RECRUITING | Rheumatoid Arthritis |
VA Office of Research and Development |
2023-03-09 | PHASE2 |
| NCT07683975 | NOT_YET_RECRUITING | Acute Kidney Injury; Acute Interstitial Nephritis |
Massachusetts General Hospital |
2026-07-16 | PHASE4 |
| NCT03804931 | RECRUITING | Ulcerative Colitis; Fecal Microbiota Transplantation |
Guangzhou First People's Hospital |
2019-01-20 | PHASE2; PHASE3 |
| NCT02784210 | RECRUITING | Multiple Sclerosis |
National Institute of Neurological Disorders and Stroke (NINDS) |
2016-10-05 | PHASE2 |
| NCT07730580 | NOT_YET_RECRUITING | Advanced Prostate Cancer |
Evopoint Biosciences Inc. |
2026-07-13 | PHASE2 |
| NCT06212583 | ACTIVE_NOT_RECRUITING | Prostate Cancer; Oligometastatic Disease |
University of Maryland, Baltimore |
2024-04-17 | PHASE2 |
| NCT07258680 | ENROLLING_BY_INVITATION | Peripheral T-cell Lymphoma |
N.N. Petrov National Medical Research Center of Oncology |
2013-10 | PHASE3 |
| NCT07719140 | RECRUITING | Childhood-onset Systemic Lupus Erythematosus; Lupus Nephritis (LN) |
Peking Union Medical College Hospital |
2026-07 | PHASE4 |
| NCT07746245 | NOT_YET_RECRUITING | Peripheral T-Cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2026-08-01 | PHASE2 |
| NCT07744724 | NOT_YET_RECRUITING | DLBCL - Diffuse Large B Cell Lymphoma; Pirtobrutinib |
Changzhou No.2 People's Hospital |
2026-07-31 | PHASE2 |
| NCT07224100 | RECRUITING | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1; Lymphoblastic Lymphoma |
University of Washington |
2026-03-30 | PHASE2 |
| NCT07418177 | NOT_YET_RECRUITING | AMD - Age-Related Macular Degeneration |
The First Affiliated Hospital with Nanjing Medical University |
2026-02-10 | PHASE1; PHASE2 |
| NCT05389423 | RECRUITING | Diffuse Large Cell Lymphoma; Non-Hodgkin Lymphoma; Burkitt Lymphoma; Plasmablastic Lymphoma; B-Cell Neoplasm |
National Cancer Institute (NCI) |
2023-06-27 | PHASE1 |
| NCT07643103 | NOT_YET_RECRUITING | Ph- Acute Lymphoblastic Leukemia (Ph-ALL) |
Institute of Hematology & Blood Diseases Hospital, China |
2026-06-12 | PHASE2 |
| NCT06136650 | RECRUITING | Metastatic Castration-resistant Prostate Cancer (mCRPC); Prostatic Neoplasms |
Merck Sharp & Dohme LLC |
2023-12-18 | PHASE3 |
| NCT03678025 | RECRUITING | Castration Levels of Testosterone; Metastatic Prostatic Adenocarcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8 |
SWOG Cancer Research Network |
2018-09-24 | PHASE3 |
| NCT03984448 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present; Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2019-10-22 | PHASE2; PHASE3 |
| NCT06091254 | RECRUITING | Follicular Lymphoma (FL) |
Regeneron Pharmaceuticals |
2023-12-12 | PHASE3 |
| NCT07676175 | NOT_YET_RECRUITING | Previously Untreated Peripheral T-Cell Lymphoma |
BeBetter Med Inc |
2026-07-01 | PHASE2 |
| NCT03719105 | RECRUITING | NK-Cell Lymphoma; NK-Cell Leukemia; Peripheral T Cell Lymphoma |
New York Medical College |
2019-03-01 | EARLY_PHASE1 |
| NCT06251232 | NOT_YET_RECRUITING | Hepatotoxicity; Idiosyncratic Drug Effect; Prednisone |
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud |
2024-05-01 | PHASE2 |
| NCT07535762 | NOT_YET_RECRUITING | Peripheral T-Cell Lymphoma (PTCL NOS); Nodal T-follicular Helper Cell Lymphoma; Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) |
Shanghai Jiao Tong University School of Medicine |
2026-03-30 | PHASE2 |
| NCT04872790 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Mixed Phenotype Acute Leukemia; Recurrent B Acute Lymphoblastic Leukemia; Recurrent Mixed Phenotype Acute Leukemia |
OHSU Knight Cancer Institute |
2022-09-02 | PHASE1 |
| NCT06624670 | RECRUITING | Pyoderma Gangrenosum |
LEO Pharma |
2025-02-05 | PHASE3 |
| NCT06971211 | RECRUITING | Metastatic Castration-resistant Prostate Cancer |
Jianbin Bi |
2024-11-27 | PHASE2 |
| NCT02861573 | ACTIVE_NOT_RECRUITING | Metastatic Castration-Resistant Prostate Cancer |
Merck Sharp & Dohme LLC |
2016-11-17 | PHASE1; PHASE2 |
| NCT03914625 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Down Syndrome |
National Cancer Institute (NCI) |
2019-07-03 | PHASE3 |
| NCT06527690 | WITHDRAWN | Prostate Cancer; Castrate Resistant Prostate Cancer; Homologous Recombination Deficiency |
Latin American Cooperative Oncology Group |
2025-04-30 | PHASE2 |
| NCT04654988 | RECRUITING | Myocarditis; Heart Failure; Endomyocardial Biopsy; Cardiomyopathies, Secondary; Immunosuppression |
Medical University of Warsaw |
2022-12-01 | PHASE4 |
| NCT07444710 | NOT_YET_RECRUITING | Ann Arbor Stage II Mantle Cell Lymphoma; Ann Arbor Stage III Mantle Cell Lymphoma; Ann Arbor Stage IV Mantle Cell Lymphoma |
National Cancer Institute (NCI) |
2026-10-30 | PHASE1 |
| NCT05818683 | RECRUITING | Metastatic Castration-resistant Prostate Neoplasms; Metastatic Hormone-sensitive Prostate Cancer |
Janssen Research & Development, LLC |
2023-04-26 | PHASE1 |
| NCT07221838 | RECRUITING | Generalized Myasthenia Gravis; gMG |
Alexion Pharmaceuticals, Inc. |
2026-03-04 | PHASE4 |
| NCT07159906 | NOT_YET_RECRUITING | Diffuse Large B-Cell Lymphoma; Relapsed Non-Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma |
First Affiliated Hospital of Zhejiang University |
2025-09-08 | PHASE1; PHASE2 |
| NCT04151082 | RECRUITING | Cranial Nerve Disorder; Head and Neck Carcinoma; Oropharyngeal Carcinoma |
M.D. Anderson Cancer Center |
2019-10-16 | PHASE1; PHASE2 |
| NCT05922761 | RECRUITING | Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease |
Dana-Farber Cancer Institute |
2024-05-31 | PHASE2 |
| NCT04469842 | RECRUITING | Lung Transplant; Complications |
Vanderbilt University Medical Center |
2023-12-01 | EARLY_PHASE1 |
| NCT05279300 | SUSPENDED | Advanced Solid Tumor; Advanced Lymphoma |
CStone Pharmaceuticals |
2022-03-28 | PHASE1 |
| NCT04301076 | RECRUITING | Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection |
National Cancer Institute (NCI) |
2021-08-31 | PHASE1 |
| NCT04812366 | RECRUITING | Prostate Cancer |
University of British Columbia |
2021-09-21 | PHASE2 |
| NCT03153527 | RECRUITING | Inflammatory Disorder; Autoimmune |
University Hospital, Basel, Switzerland |
2017-05-31 | PHASE4 |
| NCT07552324 | NOT_YET_RECRUITING | DHL; THL; DLBCL - Diffuse Large B Cell Lymphoma |
Ruijin Hospital |
2026-05-01 | PHASE2 |
| NCT04803201 | RECRUITING | Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Follicular T-Cell Lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Peripheral T-Cell Lymphoma, Not Otherwise Specified |
Alliance for Clinical Trials in Oncology |
2021-10-08 | PHASE2 |
| NCT07081022 | ACTIVE_NOT_RECRUITING | B-cell Non-Hodgkin's Lymphoma |
Shanghai Junshi Bioscience Co., Ltd. |
2025-08-17 | PHASE2 |
| NCT06500247 | NOT_YET_RECRUITING | The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer |
Qilu Hospital of Shandong University |
2024-07-31 | PHASE2 |
| NCT04529772 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
Acerta Pharma BV |
2020-10-08 | PHASE3 |
| NCT04411654 | ACTIVE_NOT_RECRUITING | Gaucher Disease, Type 2 |
Prevail Therapeutics |
2021-06-29 | PHASE1; PHASE2 |
| NCT05444946 | RECRUITING | Chronic Pulmonary Aspergillosis; Allergic Bronchopulmonary Aspergillosis |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2022-06-15 | |
| NCT05176483 | RECRUITING | Renal Cell Carcinoma (RCC); Metastatic Castration-Resistant Prostate Cancer (mCRPC); Urothelial Carcinoma (UC); Solid Tumor; Hepatocellular Carcinoma (HCC); Non-small Cell Lung Cancer (NSCLC); Colorectal Cancer (CRC); Head and Neck Squamous Cell Carcinoma (HNSCC); Clear Cell Renal Cell Carcinoma (ccRCC); Non-Clear Cell Renal Cell Carcinoma (nccRCC); Drug-Drug Interaction (DDI) |
Exelixis |
2021-12-14 | PHASE1 |
| NCT04978584 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
M.D. Anderson Cancer Center |
2022-03-03 | PHASE2 |
| NCT03755804 | ACTIVE_NOT_RECRUITING | Hodgkin Lymphoma |
St. Jude Children's Research Hospital |
2018-12-12 | PHASE2 |
| NCT03892785 | ACTIVE_NOT_RECRUITING | Giant Cell Arteritis |
Centre Hospitalier Universitaire Dijon |
2020-01-27 | PHASE3 |
| NCT03760835 | RECRUITING | Congenital Adrenal Hyperplasia |
Federico II University |
2016-08-11 | PHASE4 |
| NCT05681260 | RECRUITING | T-cell Lymphoblastic Lymphoma |
Children's Cancer Group, China |
2023-02-06 | PHASE3 |
| NCT04662580 | ACTIVE_NOT_RECRUITING | Metastatic Prostate Cancer |
Janssen Research & Development, LLC |
2021-05-03 | PHASE1 |
| NCT05958719 | RECRUITING | Peripheral T Cell Lymphoma; Epigenetic Repression |
Institute of Hematology & Blood Diseases Hospital, China |
2023-03-02 | PHASE2 |
| NCT07093866 | RECRUITING | mCRPC |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2025-07-20 | PHASE2 |
| NCT02877303 | RECRUITING | B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2016-11-01 | PHASE2 |
| NCT03595917 | RECRUITING | B-cell Acute Lymphoblastic Leukemia; Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis; Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL |
Marlise Luskin, MD |
2018-07-24 | PHASE1 |
| NCT00501826 | RECRUITING | T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2007-07-11 | PHASE2 |
| NCT03819296 | RECRUITING | Clinical Stage 0 Cutaneous Melanoma AJCC v8; Clinical Stage I Cutaneous Melanoma AJCC v8; Clinical Stage IA Cutaneous Melanoma AJCC v8; Clinical Stage IB Cutaneous Melanoma AJCC v8; Clinical Stage II Cutaneous Melanoma AJCC v8; Clinical Stage IIA Cutaneous Melanoma AJCC v8; Clinical Stage IIB Cutaneous Melanoma AJCC v8; Clinical Stage IIC Cutaneous Melanoma AJCC v8; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Colitis; Lung Non-Small Cell Carcinoma; Malignant Genitourinary System Neoplasm; Malignant Solid Neoplasm; Pathologic Stage 0 Cutaneous Melanoma AJCC v8; Pathologic Stage I Cutaneous Melanoma AJCC v8; Pathologic Stage IA Cutaneous Melanoma AJCC v8; Pathologic Stage IB Cutaneous Melanoma AJCC v8; Pathologic Stage II Cutaneous Melanoma AJCC v8; Pathologic Stage IIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIC Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Stage 0 Lung Cancer AJCC v8; Stage I Lung Cancer AJCC v8; Stage IA1 Lung Cancer AJCC v8; Stage IA2 Lung Cancer AJCC v8; Stage IA3 Lung Cancer AJCC v8; Stage IB Lung Cancer AJCC v8; Stage II Lung Cancer AJCC v8; Stage IIA Lung Cancer AJCC v8; Stage IIB Lung Cancer AJCC v8; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8 |
M.D. Anderson Cancer Center |
2021-02-21 | PHASE1 |
| NCT06090890 | RECRUITING | In-stent Restenosis |
Fu Wai Hospital, Beijing, China |
2023-10-30 | PHASE4 |
| NCT06977711 | RECRUITING | Diffuse Large B-cell Lymphoma |
The University of Texas Health Science Center at San Antonio |
2025-06-20 | PHASE1 |
| NCT04568837 | NOT_YET_RECRUITING | Spine Fusion |
Oregon Health and Science University |
2025-03-01 | PHASE4 |
| NCT03117751 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
2017-03-29 | PHASE2; PHASE3 |
| NCT05901519 | RECRUITING | Hepatocellular Carcinoma |
University of Michigan Rogel Cancer Center |
2024-02-16 | PHASE2 |
| NCT05689021 | TERMINATED | Castration-Resistant Prostate Carcinoma; Metastatic Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8 |
Mayo Clinic |
2024-03-05 | PHASE2 |
| NCT02205762 | ACTIVE_NOT_RECRUITING | Langerhans Cell Histiocytosis |
North American Consortium for Histiocytosis |
2016-11-02 | PHASE2; PHASE3 |
| NCT06005870 | RECRUITING | Diffuse Large B Cell Lymphoma |
Huazhong University of Science and Technology |
2022-11-26 | PHASE2 |
| NCT04850495 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma |
Yazeed Sawalha |
2021-11-16 | PHASE1 |
| NCT05351346 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Ruijin Hospital |
2022-06-01 | PHASE3 |
| NCT03758989 | RECRUITING | DLBCL |
University of Rochester |
2019-05-08 | PHASE2 |
| NCT07548606 | COMPLETED | Healthy |
Merck Sharp & Dohme LLC |
2026-05-11 | PHASE1 |
| NCT04739813 | ACTIVE_NOT_RECRUITING | Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Burkitt Lymphoma |
National Cancer Institute (NCI) |
2021-07-09 | PHASE1 |
| NCT06701344 | NOT_YET_RECRUITING | Enteropathy Associated T Cell Lymphoma |
Ruijin Hospital |
2024-12-04 | PHASE2 |
| NCT04748042 | ACTIVE_NOT_RECRUITING | Prostate Cancer; Castrate Sensitive Prostate Cancer; Oligometastatic Disease |
University of Michigan Rogel Cancer Center |
2021-05-28 | PHASE2 |
| NCT05934097 | WITHDRAWN | Diffuse Large B Cell Lymphoma; Transformed Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma |
Fate Therapeutics |
2022-12 | PHASE1 |
| NCT05453500 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
University of Washington |
2023-03-27 | PHASE2 |
| NCT02723994 | COMPLETED | Leukemia |
Incyte Corporation |
2016-09-30 | PHASE2 |
| NCT06921044 | NOT_YET_RECRUITING | Diffuse Large B-Cell Lymphoma |
Xiaohui He |
2025-04-16 | PHASE2 |
| NCT03269669 | ACTIVE_NOT_RECRUITING | Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Refractory Follicular Lymphoma |
National Cancer Institute (NCI) |
2018-01-23 | PHASE2 |
| NCT01933724 | UNKNOWN | Granulomatosis With Polyangiitis; Wegener Granulomatosis; Vasculitis |
University of South Florida |
2014-02-17 | PHASE3 |
| NCT00716066 | ACTIVE_NOT_RECRUITING | Autoimmune Disease; Neurologic Autoimmune Disease; Autologous Transplant Autoimmune; Multiple Sclerosis Transplant; MS Stem Cell Transplant; Multiple Sclerosis Stem Cell Transplant; Stiff Person Syndrome; HCT for Neurologic Autoimmune Disorders; CIDP Transplant; Myasthenia Gravis Transplant; Autoimmune Nervous System Disorder; Central Nervous System Vasculitis; Cerebellar Degeneration; Chronic Inflammatory Demyelinating Polyneuropathy; Lambert Eaton Myasthenic Syndrome; Myasthenia Gravis; Neuromyelitis Optica; Opsoclonus Myoclonus Syndrome; Rasmussen Subacute Encephalitis |
Fred Hutchinson Cancer Center |
2008-06 | PHASE2 |
| NCT06656962 | ACTIVE_NOT_RECRUITING | Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN) |
Renmin Hospital of Wuhan University |
2024-10-10 | PHASE1; PHASE2 |
| NCT04835870 | UNKNOWN | Non-GCB/ABC Diffuse Large B-Cell Lymphoma |
The First Affiliated Hospital of Soochow University |
2021-04-01 | PHASE2 |
| NCT06172361 | RECRUITING | Polymyalgia Rheumatica |
Zhejiang University |
2024-01-20 | PHASE3 |
| NCT05772871 | UNKNOWN | Nephrotic Syndrome in Children |
Jianhua Zhou |
2023-04-26 | PHASE4 |
| NCT05522465 | UNKNOWN | Immune Thrombocytopenia; Glucocorticoids; Child, Only |
Fujian Medical University Union Hospital |
2022-10-11 | PHASE4 |
| NCT05422066 | UNKNOWN | DLBCL Germinal Center B-Cell Type |
Li Zhiming |
2022-07-26 | PHASE2 |
| NCT05051891 | COMPLETED | Treatment-naїve Mantle Cell Lymphoma |
Beijing InnoCare Pharma Tech Co., Ltd. |
2021-12-22 | PHASE3 |
| NCT05805930 | UNKNOWN | Pericarditis |
Istituto Giannina Gaslini |
2023-06-01 | PHASE3 |
| NCT02237820 | UNKNOWN | Heart Failure; Chronic Obstructive Pulmonary Disease |
Rabin Medical Center |
2014-11 | PHASE4 |
| NCT02807805 | ACTIVE_NOT_RECRUITING | Metastatic Prostate Carcinoma; Recurrent Prostate Carcinoma; Stage IV Prostate Cancer |
Mamta Parikh |
2016-10 | PHASE2 |
| NCT03663933 | ACTIVE_NOT_RECRUITING | Lymphoproliferative Disorders; Autoimmune Lymphoproliferative; Primary T-cell Immunodeficiency Disorders; Immune System Diseases; Common Variable Immunodeficiency |
National Cancer Institute (NCI) |
2018-09-04 | PHASE2 |
| NCT03560466 | COMPLETED | Asthma |
Sanofi |
2018-06-21 | PHASE3 |
| NCT05201248 | ACTIVE_NOT_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Genmab |
2022-03-10 | PHASE1; PHASE2 |
| NCT05090384 | COMPLETED | Acute Graft vs Host Disease; Allogeneic Bone Marrow Transplantation; Adverse Effects |
John Levine |
2022-10-20 | PHASE2 |
| NCT05238064 | UNKNOWN | PI3Kδ Inhibitor; Parsaclisib; CHOP; PTCL |
Fudan University |
2022-03 | PHASE1; PHASE2 |
| NCT06505278 | UNKNOWN | Prostate Cancer |
Sun Yat-sen University |
2024-08 | PHASE2 |
| NCT04497844 | ACTIVE_NOT_RECRUITING | Metastatic Castration-sensitive Prostate Cancer |
Janssen Research & Development, LLC |
2020-09-23 | PHASE3 |
| NCT04432714 | RECRUITING | DLBCL; Untreated; MYC Gene Rearrangement |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-09 | PHASE1; PHASE2 |
| NCT03764540 | TERMINATED | Metastatic Prostate Cancer |
Centre hospitalier de l'Université de Montréal (CHUM) |
2019-04-01 | PHASE2 |
| NCT05458180 | UNKNOWN | Peripheral T-cell Lymphoma |
Tianjin Medical University Cancer Institute and Hospital |
2022-07-07 | PHASE1 |
| NCT01940094 | COMPLETED | Granulomatosis With Polyangiitis |
University of Pennsylvania |
2014-02 | PHASE3 |
| NCT04179864 | TERMINATED | Metastatic Prostate Cancer; Metastatic Castration-resistant Prostate Cancer |
Epizyme, Inc. |
2019-11-18 | PHASE1; PHASE2 |
| NCT03220022 | ACTIVE_NOT_RECRUITING | AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2018-03-16 | PHASE1 |
| NCT04146207 | COMPLETED | Chronic GVHD |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2020-04-02 | EARLY_PHASE1 |
| NCT04980222 | ACTIVE_NOT_RECRUITING | Lymphoma |
Hoffmann-La Roche |
2022-03-22 | PHASE2 |
| NCT05267600 | COMPLETED | Bullous Pemphigoid |
argenx |
2022-06-09 | PHASE2; PHASE3 |
| NCT03711448 | COMPLETED | Patients Relapsing Refractory Giant Cell Arteritis |
Centre Hospitalier Universitaire Dijon |
2019-01-07 | PHASE2 |
| NCT04314193 | UNKNOWN | Sarcoidosis, Pulmonary |
Erasmus Medical Center |
2020-06-01 | PHASE4 |
| NCT05887726 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Liaoning Cancer Hospital & Institute |
2023-08-01 | PHASE2 |
| NCT06337695 | Not yet recruiting | Cancer|Cancer Metastatic |
University of Calgary |
2024-07-01 | Phase 2|Phase 3 |
| NCT05666336 | UNKNOWN | Systemic Lupus Erythematosus |
Fen Li |
2022-12-31 | PHASE4 |
| NCT04294641 | COMPLETED | Chronic GVHD |
National Cancer Institute (NCI) |
2021-05-10 | PHASE2 |
| NCT05211336 | ACTIVE_NOT_RECRUITING | Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS); Aggressive B-cell Lymphoma With Secondary Involvement of the CNS |
National Cancer Institute (NCI) |
2022-04-19 | PHASE1 |
| NCT06394063 | Not yet recruiting | Systemic Lupus Erythematosus |
RenJi Hospital |
2024-06-30 | Not Applicable |
| NCT04666129 | COMPLETED | Metastatic Castration-Resistant Prostate Cancer; Metastatic Castration-Sensitive Prostate Cancer; Non-Metastatic Castration-Resistant Prostate Cancer |
Sumitomo Pharma America, Inc. |
2021-02-18 | PHASE1 |
| NCT06360068 | Not yet recruiting | Systemic Lupus Erythematosus |
Qiong Fu|RenJi Hospital |
2024-05-06 | Phase 2 |
| NCT02496585 | COMPLETED | Lung Cancer; Lung Metastases |
Memorial Sloan Kettering Cancer Center |
2015-07-08 | PHASE2 |
| NCT06037811 | Not yet recruiting | Inflammatory Arthritis|Immune-related Adverse Event |
Tom Appleton|Canadian Research Group in Immuno-Oncology|Western University|Lawson Health Research Institute |
2024-04 | Phase 2 |
| NCT04169100 | UNKNOWN | Long QT Syndrome; Connective Tissue Diseases; Rheumatoid Arthritis |
Narrows Institute for Biomedical Research |
2011-09-28 | PHASE4 |
| NCT03505762 | ACTIVE_NOT_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Wake Forest University Health Sciences |
2018-07-19 | PHASE2 |
| NCT04598477 | TERMINATED | Pemphigus Vulgaris; Pemphigus Foliaceus |
argenx |
2021-07-15 | PHASE3 |
| NCT04974996 | WITHDRAWN | Diffuse Large B-Cell Lymphoma |
ADC Therapeutics S.A. |
2022-02-01 | PHASE1 |
| NCT06124703 | UNKNOWN | Hearing Loss; Tinnitus; Sensorineural Hearing Loss |
Eye & ENT Hospital of Fudan University |
2023-11-10 | |
| NCT00390793 | COMPLETED | Acute Lymphoblastic Leukemia; BCR-ABL1 Fusion Protein Expression; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Recurrent Acute Lymphoblastic Leukemia; t(9;22) |
M.D. Anderson Cancer Center |
2006-09-28 | PHASE2 |
| NCT04918147 | TERMINATED | IgG4 Related Disease; IgG4-RD |
National Institute of Allergy and Infectious Diseases (NIAID) |
2021-10-13 | PHASE2 |
| NCT04214626 | COMPLETED | Diffuse Large B Cell Lymphoma |
Henan Cancer Hospital |
2020-01-05 | PHASE2 |
| NCT04922567 | RECRUITING | Peripheral T-Cell Lymphoma; Lenalidomide; CHOP |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2021-04-01 | PHASE2 |
| NCT03970577 | UNKNOWN | Minimal Change Nephrotic Syndrome (MCNS) |
Assistance Publique - Hôpitaux de Paris |
2020-07-29 | PHASE2 |
| NCT03847272 | TERMINATED | Patients With Newly Diagnosed Active NISU |
Centre Hospitalier Universitaire Dijon |
2019-08-01 | PHASE2 |
| NCT03012321 | ACTIVE_NOT_RECRUITING | Prostate Cancer Metastatic Castration-Resistant; Abnormal DNA Repair; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer |
Northwestern University |
2017-01-12 | PHASE2 |
| NCT02506192 | COMPLETED | Chronic Inflammation; Chronic Pain; Fatigue; Cognitive Impairment |
Minneapolis Veterans Affairs Medical Center |
2015-07 | PHASE2 |
| NCT02626455 | TERMINATED | Lymphoma, Non-Hodgkin |
Bayer |
2016-01-06 | PHASE3 |
| NCT04598451 | COMPLETED | Pemphigus Vulgaris; Pemphigus Foliaceus |
argenx |
2020-12-01 | PHASE3 |
| NCT00488605 | WITHDRAWN | Leukemia |
University of New Mexico |
2023-08-01 | PHASE3 |
| NCT02348216 | COMPLETED | Refractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma (TFL); Primary Mediastinal B-cell Lymphoma (PMBCL); High Grade B-cell Lymphoma (HGBCL) |
Kite, A Gilead Company |
2015-04-21 | PHASE1; PHASE2 |
| NCT04773366 | UNKNOWN | Langerhans Cell Histiocytosis |
Shanghai Children's Medical Center |
2018-07-01 | PHASE3 |
| NCT04339062 | COMPLETED | Cutaneous Squamous Cell Carcinoma; Advanced Cancer |
Dana-Farber Cancer Institute |
2020-11-03 | PHASE1; PHASE2 |
| NCT04480099 | UNKNOWN | Peripheral T-cell Lymphoma |
Ruijin Hospital |
2020-07-29 | PHASE2 |
| NCT05247554 | UNKNOWN | Pulmonary Sarcoidosis |
Assistance Publique - Hôpitaux de Paris |
2022-03-01 | PHASE3 |
| NCT04842318 | UNKNOWN | Follicular Lymphoma |
Ruijin Hospital |
2021-03-01 | PHASE4 |
| NCT05003713 | COMPLETED | Healthy |
Corcept Therapeutics |
2021-08-03 | PHASE1 |
| NCT05931744 | COMPLETED | Chronic Rhinosinusitis With Nasal Polyps |
Kafrelsheikh University |
2021-05-01 | PHASE2; PHASE3 |
| NCT02661503 | UNKNOWN | Classical Hodgkin Lymphoma |
University of Cologne |
2016-07 | PHASE3 |
| NCT02752815 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Ruijin Hospital |
2016-06-14 | PHASE4 |
| NCT02636322 | COMPLETED | Diffuse Large B-Cell Lymphoma Unclassifiable |
M.D. Anderson Cancer Center |
2016-03-29 | PHASE2 |
| NCT05084859 | TERMINATED | Castration-resistant Prostate Cancer; Non-small Cell Lung Cancer; Colorectal Cancer |
Biosplice Therapeutics, Inc. |
2021-11-03 | PHASE1 |
| NCT03991884 | COMPLETED | Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma |
University of Washington |
2019-09-24 | PHASE1 |
| NCT04536662 | UNKNOWN | Congenital Adrenal Hyperplasia |
Shanghai Jiao Tong University School of Medicine |
2020-10-01 | PHASE4 |
| NCT04903054 | WITHDRAWN | Kidney Transplantation; Renal Transplant Recipients |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-01-10 | PHASE2 |
| NCT04706741 | COMPLETED | Uveitis |
ACELYRIN Inc. |
2022-01-06 | PHASE2 |
| NCT03589326 | ACTIVE_NOT_RECRUITING | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) |
Takeda |
2018-10-04 | PHASE3 |
| NCT04907227 | TERMINATED | Prostatic Neoplasms |
Merck Sharp & Dohme LLC |
2020-09-23 | PHASE3 |
| NCT05284942 | UNKNOWN | Rosai-Dorfman Disease; Langerhans Cell Histiocytosis |
Tongji Hospital |
2011-10-01 | PHASE4 |
| NCT04882683 | UNKNOWN | Ulcerative Colitis |
Shandong Qilu Stem Cells Engineering Co., Ltd. |
2021-06-01 | |
| NCT05333744 | UNKNOWN | Immune Thrombocytopenia |
Peking University People's Hospital |
2021-06-01 | PHASE2 |
| NCT00551928 | COMPLETED | Multiple Myeloma; Newly Diagnosed Patients |
Fondazione EMN Italy Onlus |
2007-06 | PHASE3 |
| NCT01974440 | COMPLETED | Lymphoma |
Janssen Research & Development, LLC |
2014-01-31 | PHASE3 |
| NCT04072822 | COMPLETED | Alcoholic Hepatitis |
Indiana University |
2020-07-10 | PHASE2 |
| NCT04660799 | COMPLETED | Lymphoma, Large B-Cell, Diffuse |
Hoffmann-La Roche |
2021-02-24 | PHASE2 |
| NCT04357392 | UNKNOWN | Diabetes Mellitus, Type 2 |
chenfengling |
2020-05-20 | EARLY_PHASE1 |
| NCT03003520 | COMPLETED | Lymphoma, Large B-Cell, Diffuse |
Celgene |
2017-02-28 | PHASE2 |
| NCT03187743 | COMPLETED | Lupus Erythematosus, Systemic |
Assistance Publique - Hôpitaux de Paris |
2018-04-17 | |
| NCT02903368 | COMPLETED | Prostate Cancer |
Dana-Farber Cancer Institute |
2016-10-19 | PHASE2 |
| NCT01925131 | COMPLETED | Acute Leukemias of Ambiguous Lineage; B-cell Adult Acute Lymphoblastic Leukemia; Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma |
SWOG Cancer Research Network |
2014-06-13 | PHASE1 |
| NCT02166463 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage IIB Hodgkin Lymphoma; Ann Arbor Stage IIIB Hodgkin Lymphoma; Ann Arbor Stage IVA Hodgkin Lymphoma; Ann Arbor Stage IVB Hodgkin Lymphoma; Childhood Hodgkin Lymphoma; Classic Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2015-03-19 | PHASE3 |
| NCT03726749 | COMPLETED | Giant Cell Arteritis |
Massachusetts General Hospital |
2018-11-28 | PHASE4 |
| NCT03218852 | UNKNOWN | IgA Nephropathy |
Guangdong Provincial People's Hospital |
2016-12 | PHASE4 |
| NCT03565835 | COMPLETED | Prostatic Neoplasms |
Montefiore Medical Center |
2018-06-13 | PHASE2 |
| NCT03692416 | UNKNOWN | Vasculitis |
Assiut University |
2018-11-11 | PHASE3 |
| NCT02909335 | WITHDRAWN | Liver Transplantation |
Rennes University Hospital |
2016-11 | PHASE3 |
| NCT03632187 | COMPLETED | Polymyalgia Rheumatica |
University Hospital, Brest |
2018-12-13 | PHASE3 |
| NCT02918747 | UNKNOWN | Lymphoma |
Hunan Cancer Hospital |
2016-09 | PHASE2 |
| NCT03492255 | TERMINATED | Systemic Lupus Erythematosus (SLE) |
University of Sao Paulo General Hospital |
2018-04-12 | |
| NCT04492358 | TERMINATED | Covid19 |
Maria Joyera Rodríguez |
2020-10-22 | PHASE2; PHASE3 |
| NCT02543255 | COMPLETED | Prostate Cancer |
University Health Network, Toronto |
2016-09 | PHASE2 |
| NCT03279250 | COMPLETED | Prostate Adenocarcinoma; Stage IIB Prostate Cancer AJCC v8; Stage IIC Prostate Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8 |
M.D. Anderson Cancer Center |
2017-10-13 | PHASE2 |
| NCT00670358 | COMPLETED | Lymphoma |
Mayo Clinic |
2008-08-25 | PHASE1; PHASE2 |
| NCT03356912 | UNKNOWN | Prostate Cancer; Castration-resistant Prostate Cancer |
Consorzio Oncotech |
2017-11-22 | PHASE2 |
| NCT04534478 | UNKNOWN | COVID-19 Pneumonia |
Hospital Universitari Vall d'Hebron Research Institute |
2020-09-07 | PHASE4 |
| NCT01517802 | COMPLETED | Metastatic Castration-resistant Prostate Cancer; Metastatic Breast Cancer |
Janssen Research & Development, LLC |
2012-03-28 | PHASE3 |
| NCT04356430 | UNKNOWN | Prostate Cancer |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2019-04-01 | PHASE2 |
| NCT02370550 | UNKNOWN | Sjogren's Syndrome |
Peking University People's Hospital |
2015-03 | PHASE4 |
| NCT03761225 | COMPLETED | Metastatic Castrate Resistant Prostate Cancer |
AB Science |
2014-09 | PHASE3 |
| NCT02921789 | COMPLETED | Kidney Transplantation; Primary Focal Segmental Glomerulosclerosis (FSGS) |
Astellas Pharma Global Development, Inc. |
2017-05-22 | PHASE2 |
| NCT03121690 | UNKNOWN | Pneumonia Hospital Acquired |
Assiut University |
2017-12-01 | PHASE4 |
| NCT02767674 | UNKNOWN | Diffuse Large B Cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2016-05 | PHASE3 |
| NCT01208766 | COMPLETED | Multiple Myeloma |
Stichting Hemato-Oncologie voor Volwassenen Nederland |
2011-01 | PHASE3 |
| NCT03617432 | UNKNOWN | Experimental Tumor |
Peking University |
2018-08-28 | PHASE2 |
| NCT03412565 | COMPLETED | Multiple Myeloma |
Janssen Research & Development, LLC |
2018-04-26 | PHASE2 |
| NCT01054144 | COMPLETED | Multiple Myeloma |
H. Lee Moffitt Cancer Center and Research Institute |
2010-01-14 | PHASE2 |
| NCT03150056 | TERMINATED | Solid Tumours |
GlaxoSmithKline |
2017-07-18 | PHASE1 |
| NCT03217812 | COMPLETED | Multiple Myeloma |
Janssen Research & Development, LLC |
2017-11-23 | PHASE3 |
| NCT02532777 | UNKNOWN | Henoch-Schoenlein Purpura Nephritis |
Nanjing Children's Hospital |
2015-08 | PHASE2 |
| NCT03974867 | UNKNOWN | Vestibular Vertigo; Sudden Hearing Loss |
Eye & ENT Hospital of Fudan University |
2019-07 | |
| NCT03424733 | UNKNOWN | Multiple Sclerosis |
Holy Name Medical Center, Inc. |
2017-09-25 | PHASE4 |
| NCT03161054 | COMPLETED | Aggressive Non-Hodgkin Lymphoma |
Fondazione Italiana Linfomi - ETS |
2017-09-12 | PHASE2 |
| NCT01356680 | COMPLETED | Hodgkin Lymphoma |
University of Cologne |
2012-01-13 | PHASE3 |
| NCT01503229 | COMPLETED | Hormone-Resistant Prostate Cancer; Metastatic Prostate Carcinoma; Recurrent Prostate Carcinoma; Stage IV Prostate Adenocarcinoma |
University of Washington |
2012-12 | PHASE2 |
| NCT02987244 | UNKNOWN | T Cell Non-Hodgkin's Lymphoma |
Peking Union Medical College Hospital |
2016-03 | PHASE1; PHASE2 |
| NCT03304626 | COMPLETED | Acute Cellular Graft Rejection; New Onset Diabetes After Transplant |
University of Cincinnati |
2017-06-27 | PHASE2 |
| NCT03110588 | WITHDRAWN | Metastatic Prostate Cancer |
University of Alabama at Birmingham |
2018-05-09 | PHASE1 |
| NCT03598725 | UNKNOWN | Hemophilia A With Inhibitor |
Beijing Children's Hospital |
2016-01-01 | PHASE4 |
| NCT02858804 | COMPLETED | Mantle Cell Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2016-01 | PHASE4 |
| NCT00058422 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2003-02-10 | PHASE2 |
| NCT03833596 | TERMINATED | Crohn's Disease |
McMaster University |
2018-10-25 | PHASE4 |
| NCT01940276 | COMPLETED | Prostate Cancer |
Duke University |
2013-10 | PHASE2 |
| NCT02449278 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Wuhan University |
2015-10 | PHASE3 |
| NCT02994927 | COMPLETED | ANCA-Associated Vasculitis |
Amgen |
2017-03-15 | PHASE3 |
| NCT02924766 | COMPLETED | Prostatic Neoplasms |
Janssen Research & Development, LLC |
2016-10-03 | PHASE1 |
| NCT01946880 | TERMINATED | Systemic Lupus Erythematosus; SLE |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-11-20 | PHASE2 |
| NCT02879526 | UNKNOWN | Relapse/Refratory Peripheral T Cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2016-08 | PHASE2 |
| NCT01889069 | COMPLETED | Lymphoma |
Hoffmann-La Roche |
2013-07-31 | PHASE3 |
| NCT03098823 | COMPLETED | Lupus Erythematosus, Systemic; Lupus Erythematosus; Fatigue |
Ampel BioSolutions, LLC |
2017-09-12 | PHASE4 |
| NCT03093272 | TERMINATED | Prostate Cancer |
Dana-Farber Cancer Institute |
2017-06-23 | PHASE2 |
| NCT02951728 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Ruijin Hospital |
2016-10 | PHASE1; PHASE2 |
| NCT03269747 | COMPLETED | Brown Adipose Tissue |
University Hospital, Basel, Switzerland |
2017-12-06 | PHASE4 |
| NCT02485691 | COMPLETED | Prostate Cancer Metastatic |
Sanofi |
2015-11-09 | PHASE4 |
| NCT02285062 | COMPLETED | Lymphoma, Large B-Cell, Diffuse |
Celgene |
2015-02-17 | PHASE3 |
| NCT03315338 | COMPLETED | Healthy |
Corcept Therapeutics |
2017-09-15 | PHASE1 |
| NCT02550652 | COMPLETED | Lupus Nephritis |
Hoffmann-La Roche |
2015-11-13 | PHASE2 |
| NCT02344017 | COMPLETED | Prostate Cancer |
Orion Corporation, Orion Pharma |
2015-02 | PHASE1; PHASE2 |
| NCT01992653 | COMPLETED | Lymphoma, Non Hodgkin |
Genentech, Inc. |
2013-11-29 | PHASE1; PHASE2 |
| NCT02849990 | COMPLETED | Stage III Prostate Adenocarcinoma AJCC v7; Stage III Prostate Cancer AJCC v7; Stage IV Prostate Adenocarcinoma AJCC v7; Stage IV Prostate Cancer AJCC v7 |
University of Washington |
2017-03-09 | PHASE2 |
| NCT02927834 | COMPLETED | Sinusitis |
Loma Linda University |
2015-08 | |
| NCT02237261 | COMPLETED | Multiple Myeloma |
University Hospital Heidelberg |
2014-11 | PHASE2 |
| NCT01893658 | WITHDRAWN | Acute Interstitial Nephritis |
Mayo Clinic |
2018-06-01 | PHASE2 |
| NCT02953873 | COMPLETED | Immunosuppression |
Medical University of South Carolina |
2017-05-05 | PHASE4 |
| NCT00278421 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2005-11 | PHASE3 |
| NCT03367663 | COMPLETED | Atherosclerosis; Dyslipidemias; Diabetes |
Prof. Tony hayek MD |
2018-01-17 | EARLY_PHASE1 |
| NCT03188198 | UNKNOWN | Large B Cell Lymphoma |
Mansoura University |
2016-06-01 | PHASE2 |
| NCT02556866 | TERMINATED | Cryoglobulinemia; Systemic Vasculitis |
Assistance Publique - Hôpitaux de Paris |
2015-07-17 | PHASE2 |
| NCT03335956 | COMPLETED | Healthy |
Corcept Therapeutics |
2017-09-21 | PHASE1 |
| NCT02453009 | COMPLETED | Prostatic Neoplasms |
Santa Chiara Hospital |
2014-10 | PHASE2 |
| NCT02119273 | WITHDRAWN | Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) |
Loma Linda University |
2014-09 | PHASE4 |
| NCT02531633 | TERMINATED | Giant Cell Arteritis |
GlaxoSmithKline |
2015-10-16 | PHASE3 |
| NCT00352794 | COMPLETED | Myelofibrosis |
M.D. Anderson Cancer Center |
2006-07-07 | PHASE2 |
| NCT01622439 | COMPLETED | Diffuse Large B-cell Lymphoma |
Lund University Hospital |
2012-06 | PHASE1; PHASE2 |
| NCT00278408 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2006-01-02 | PHASE3 |
| NCT02129764 | COMPLETED | Heart Failure, Hyperuricemia |
Hebei Medical University |
2013-12 | PHASE2; PHASE3 |
| NCT02953678 | COMPLETED | Graft-versus-host Disease (GVHD) |
Incyte Corporation |
2016-12-30 | PHASE2 |
| NCT02206425 | COMPLETED | Multiple Myeloma |
Oncotherapeutics |
2014-09 | PHASE1; PHASE2 |
| NCT02809079 | UNKNOWN | Neuromyelitis Optica Spectrum Disorders; Mycophenolate Mofetil; Efficacy and Safety |
Third Affiliated Hospital, Sun Yat-Sen University |
2016-01 | PHASE4 |
| NCT02195479 | COMPLETED | Multiple Myeloma |
Janssen Research & Development, LLC |
2014-12-09 | PHASE3 |
| NCT01156883 | COMPLETED | Leukemia |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2010-04 | |
| NCT02914054 | COMPLETED | ITP; Croticosteroid Therapy |
Isfahan University of Medical Sciences |
2016-10-01 | PHASE2; PHASE3 |
| NCT02451748 | COMPLETED | Rheumatoid Arthritis |
University of Illinois at Chicago |
2015-08 | PHASE4 |
| NCT00801281 | COMPLETED | Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma; Lymphoplasmacytic Lymphoma |
Polish Lymphoma Research Group |
2007-02 | PHASE3 |
| NCT02419469 | TERMINATED | Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma |
M.D. Anderson Cancer Center |
2015-11-13 | PHASE2 |
| NCT02380313 | WITHDRAWN | Cancer |
GlaxoSmithKline |
2015-10 | PHASE1 |
| NCT02559791 | COMPLETED | Severe Persistent Asthma; Eosinophilic Bronchitis |
McMaster University |
2015-10 | PHASE2; PHASE3 |
| NCT02689960 | COMPLETED | Adrenal Insufficiency |
Wuerzburg University Hospital |
2017-01 | PHASE2 |
| NCT01106833 | COMPLETED | Chronic GVHD |
Medical College of Wisconsin |
2010-04 | PHASE2; PHASE3 |
| NCT02702778 | TERMINATED | Polymyalgia Rheumatica |
Dinora, Inc. |
2016-02 | PHASE2 |
| NCT01336933 | COMPLETED | Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma |
University of Nebraska |
2011-07-06 | PHASE2 |
| NCT02116556 | UNKNOWN | Alcoholic Hepatitis |
Hospital Universitari Vall d'Hebron Research Institute |
2013-04 | PHASE2 |
| NCT02595242 | WITHDRAWN | Diffuse Large B Cell Lymphoma |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2015-06 | PHASE1 |
| NCT02208583 | UNKNOWN | Hormone Refractory Prostate Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2014-06 | |
| NCT01471340 | COMPLETED | Asthma |
Organon and Co |
2012-01-09 | PHASE4 |
| NCT01714817 | TERMINATED | Lupus Nephritis |
Bristol-Myers Squibb |
2013-01-22 | PHASE3 |
| NCT01193842 | COMPLETED | AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage I Grade 3 Follicular Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; HIV Infection; Plasmablastic Lymphoma; Primary Effusion Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma |
National Cancer Institute (NCI) |
2010-10-06 | PHASE1; PHASE2 |
| NCT01235689 | COMPLETED | Crohn's Disease |
AbbVie (prior sponsor, Abbott) |
2011-02-11 | PHASE3 |
| NCT00348816 | TERMINATED | Prostate Cancer |
The University of Texas Health Science Center at San Antonio |
2006-05 | PHASE2 |
| NCT02531308 | TERMINATED | Diffuse Large B-Cell Lymphoma |
Rush University Medical Center |
2015-07 | PHASE2 |
| NCT01981889 | COMPLETED | Inflammatory Bowel Disease 11 |
University of British Columbia |
2013-10 | PHASE4 |
| NCT00450385 | TERMINATED | Lymphoma |
University of Miami |
2007-04-24 | PHASE2 |
| NCT01791153 | COMPLETED | Giant Cell Arteritis |
Hoffmann-La Roche |
2013-07-22 | PHASE3 |
| NCT01895049 | COMPLETED | Kidney Transplantation; Cytomegalovirus |
Helio Tedesco Silva Junior |
2013-08 | PHASE4 |
| NCT01685125 | UNKNOWN | Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate Cancer |
University of Southern California |
2012-09 | PHASE2 |
| NCT00381680 | COMPLETED | B-cell Childhood Acute Lymphoblastic Leukemia; L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2007-03 | PHASE3 |
| NCT01332968 | COMPLETED | Non-Hodgkin's Lymphoma |
Hoffmann-La Roche |
2011-07-06 | PHASE3 |
| NCT01132807 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2010-05 | PHASE2 |
| NCT00657410 | COMPLETED | Nonneoplastic Condition |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2008-04 | PHASE3 |
| NCT01839097 | COMPLETED | Peripheral T-cell Lymphoma |
Acrotech Biopharma Inc. |
2013-05 | PHASE1 |
| NCT01393730 | COMPLETED | Prostate Cancer |
Mary-Ellen Taplin, MD |
2011-09 | PHASE2 |
| NCT00972478 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage II Non-Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2010-11-15 | PHASE1; PHASE2 |
| NCT00972660 | UNKNOWN | Graft Versus Host Disease |
Guangdong Provincial People's Hospital |
2009-09 | PHASE2 |
| NCT02182622 | WITHDRAWN | Prostate Cancer |
Martin Gutierrez |
2014-07 | PHASE1 |
| NCT00634179 | COMPLETED | Lymphoma, B-Cell; Follicular Lymphoma |
Emory University |
2008-02 | PHASE1; PHASE2 |
| NCT00294658 | COMPLETED | Myasthenia Gravis |
University of Alabama at Birmingham |
2006-06 | PHASE3 |
| NCT02058875 | WITHDRAWN | Cardiovascular Disease; Cardiovascular Outcomes; Kidney Transplant Recipients; Kidney Transplantation |
University of Saskatchewan |
2014-02 | PHASE4 |
| NCT01485861 | COMPLETED | Prostate Cancer |
Genentech, Inc. |
2012-01-11 | PHASE1; PHASE2 |
| NCT01621386 | COMPLETED | Asthma |
Hal C Charles |
2013-01 | PHASE1 |
| NCT01023061 | COMPLETED | Adenocarcinoma of the Prostate; Stage II Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer |
University of Washington |
2010-03 | PHASE2 |
| NCT01877746 | UNKNOWN | Inflammatory Cardiomyopathy |
St. Anne's University Hospital Brno, Czech Republic |
2013-01 | PHASE3 |
| NCT01452100 | TERMINATED | Cholesterol Embolism Systemic |
University Hospital, Toulouse |
2011-06 | PHASE2 |
| NCT01671423 | COMPLETED | Cellulitis |
Albert Einstein Healthcare Network |
2012-08 | |
| NCT00931918 | COMPLETED | Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL) |
Millennium Pharmaceuticals, Inc. |
2009-10 | PHASE2 |
| NCT01718353 | COMPLETED | Prostate Cancer Metastatic |
Sanofi |
2013-03 | PHASE2 |
| NCT01385228 | COMPLETED | Prostate Cancer |
Daniel George, MD |
2011-06 | PHASE1 |
| NCT01900431 | COMPLETED | Uveitis |
Sanofi |
2013-10 | PHASE2 |
| NCT02054793 | WITHDRAWN | Prostate Cancer; Castration-resistant Prostate Cancer |
Emmanuel Antonarakis, MD |
2014-06 | PHASE1; PHASE2 |
| NCT01172639 | COMPLETED | Rheumatoid Arthritis |
P. Verschueren |
2009-02 | PHASE4 |
| NCT02463331 | COMPLETED | Autoimmune Hepatitis |
University of Sao Paulo General Hospital |
2003-05 | PHASE4 |
| NCT00352027 | COMPLETED | Hodgkin's Lymphoma |
St. Jude Children's Research Hospital |
2006-07-20 | PHASE2 |
| NCT02072200 | COMPLETED | Rheumatoid Arthritis |
Mundipharma Korea Ltd |
2013-09 | PHASE4 |
| NCT01848067 | COMPLETED | Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate Cancer |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2013-08-14 | PHASE1; PHASE2 |
| NCT02036463 | WITHDRAWN | Duchenne Muscular Dystrophy (DMD) |
Ann & Robert H Lurie Children's Hospital of Chicago |
2014-11 | PHASE2 |
| NCT02334813 | COMPLETED | Purpura, Thrombocytopenic, Idiopathic |
University Hospital, Essen |
2002-07 | PHASE3 |
| NCT01549951 | COMPLETED | Prostate Cancer |
Millennium Pharmaceuticals, Inc. |
2012-05 | PHASE2 |
| NCT02072863 | COMPLETED | Multiple Myeloma |
Amgen |
2014-01 | PHASE1; PHASE2 |
| NCT01411514 | TERMINATED | Multiple Sclerosis |
Claudio Gobbi |
2011-08 | PHASE4 |
| NCT02159690 | WITHDRAWN | Prostate Cancer; Localized Prostate Cancer |
Kenneth Pienta, MD |
2014-09 | PHASE2 |
| NCT00651040 | COMPLETED | Polymyositis; Dermatomyositis |
Institute of Rheumatology, Prague |
2008-05 | PHASE3 |
| NCT01746173 | TERMINATED | T-cell Non-Hodgkin Lymphoma |
Dana-Farber Cancer Institute |
2013-07 | PHASE2 |
| NCT00051311 | COMPLETED | Hematologic Neoplasms |
National Cancer Institute (NCI) |
2003-01-03 | PHASE2 |
| NCT00101010 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
2005-09 | PHASE2 |
| NCT02190994 | UNKNOWN | Pituitary Neoplasms; Craniopharyngiomas |
West China Hospital |
2013-08 | PHASE4 |
| NCT01685268 | COMPLETED | Prostate Cancer |
Astex Pharmaceuticals, Inc. |
2012-09 | PHASE1; PHASE2 |
| NCT00866307 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2009-02-23 | PHASE1 |
| NCT01780844 | COMPLETED | Kidney Transplantation |
Astellas Pharma Global Development, Inc. |
2013-03-05 | PHASE2 |
| NCT01695135 | COMPLETED | Prostate Neoplasms |
Janssen Research & Development, LLC |
2012-08-09 | PHASE3 |
| NCT01376401 | COMPLETED | Multiple Myeloma |
PETHEMA Foundation |
2011-07 | PHASE2 |
| NCT01254513 | COMPLETED | Prostate Cancer |
UNICANCER |
2010-12-09 | PHASE2 |
| NCT01821040 | TERMINATED | Polymyalgia Rheumatica |
Mundipharma Research Limited |
2013-03 | PHASE3 |
| NCT01415765 | WITHDRAWN | Lymphoma, Diffuse Large-Cell B-cell; Diffuse, Large B-cell Lymphoma; Lymphoma, Diffuse Large-Cell; Large-Cell Lymphoma, Diffuse |
National Cancer Institute (NCI) |
2011-07-15 | PHASE1; PHASE2 |
| NCT01414855 | COMPLETED | Lymphoma, B-Cell |
Genentech, Inc. |
2011-08-31 | PHASE2 |
| NCT01314118 | COMPLETED | Prostate Cancer; Prostatic Neoplasm |
Janssen Biotech, Inc. |
2011-05-04 | PHASE2 |
| NCT01349270 | COMPLETED | Demyelinating Polyneuropathy |
Centre Hospitalier Universitaire de Saint Etienne |
2004-06 | PHASE3 |
| NCT01814865 | WITHDRAWN | Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer |
British Columbia Cancer Agency |
2013-05 | PHASE2 |
| NCT00107380 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2005-11 | PHASE2 |
| NCT00650091 | COMPLETED | Pulmonary Fibrosis |
Duke University |
2009-10 | PHASE3 |
| NCT01717898 | TERMINATED | Castrate-resistant Prostate Cancer |
Charles Ryan |
2013-01-31 | PHASE1; PHASE2 |
| NCT01378091 | COMPLETED | Prostate Cancer |
Columbia University |
2005-08 | PHASE1 |
| NCT01004991 | COMPLETED | Diffuse Large B Cell Lymphoma |
Weill Medical College of Cornell University |
2010-01 | PHASE1; PHASE2 |
| NCT01234025 | COMPLETED | Castrate-Resistant Prostate Cancer |
Ionis Pharmaceuticals, Inc. |
2010-11 | PHASE1; PHASE2 |
| NCT00507416 | COMPLETED | Multiple Myeloma |
Millennium Pharmaceuticals, Inc. |
2007-06 | PHASE3 |
| NCT01088529 | COMPLETED | Prostate Cancer |
Cougar Biotechnology, Inc. |
2009-12 | PHASE2 |
| NCT01364389 | TERMINATED | Polymyalgia Rheumatica; Inflammatory Diseases |
Novartis Pharmaceuticals |
2011-02-14 | PHASE2 |
| NCT01084655 | COMPLETED | Prostate Cancer |
Millennium Pharmaceuticals, Inc. |
2010-07 | PHASE1; PHASE2 |
| NCT00911183 | COMPLETED | Lymphoma |
Institut Bergonié |
2008-12-02 | PHASE2 |
| NCT00184002 | COMPLETED | Non-Hodgkin's Lymphoma |
University of Southern California |
2003-01-10 | PHASE2 |
| NCT00956059 | UNKNOWN | Focal Segmental Glomerulosclerosis |
Xi'an Jiaotong University |
2009-09 | |
| NCT00376961 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2006-08 | PHASE2 |
| NCT01230788 | TERMINATED | Leukemia; Acute Lymphoblastic Leukemia; ALL |
Emory University |
2010-09 | |
| NCT01155791 | TERMINATED | Urologic Neoplasms; Prostate Cancer; Prostate Cancer Metastatic Disease |
Sandy Srinivas |
2010-04 | PHASE1 |
| NCT00744497 | COMPLETED | Prostatic Neoplasms |
Bristol-Myers Squibb |
2008-10 | PHASE3 |
| NCT01040871 | COMPLETED | Diffuse Large B-Cell Lymphoma |
Millennium Pharmaceuticals, Inc. |
2010-01 | PHASE2 |
| NCT00268853 | COMPLETED | Diffuse Large-Cell Lymphoma |
CTI BioPharma |
2005-11 | PHASE2 |
| NCT00857324 | TERMINATED | Multiple Myeloma |
Tiziana Marangon |
2009-03 | PHASE1; PHASE2 |
| NCT01711827 | COMPLETED | Healthy Subjects; Pharmacokinetics of Isavuconazole; Pharmacokinetics of Prednisolone |
Astellas Pharma Global Development, Inc. |
2012-02 | PHASE1 |
| NCT00815919 | COMPLETED | Chronic Graft Versus Host Disease |
Dana-Farber Cancer Institute |
2008-12 | PHASE2 |
| NCT00430118 | COMPLETED | Leukemia |
University Hospital Schleswig-Holstein |
2000-07 | PHASE3 |
| NCT00089609 | COMPLETED | Prostatic Neoplasms |
National Cancer Institute (NCI) |
2005-04-19 | PHASE2 |
| NCT01532856 | UNKNOWN | Multiple Myeloma |
Grupo de Estudos Multicentricos em Onco-Hematologia |
2007-01 | PHASE3 |
| NCT00184041 | COMPLETED | Acute Lymphoblastic Leukemia |
University of Southern California |
2004-07 | PHASE2 |
| NCT01683552 | COMPLETED | ITCH |
Campus Bio-Medico University |
2010-09 | PHASE2 |
| NCT00049673 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
NCIC Clinical Trials Group |
2002-10-15 | PHASE3 |
| NCT01478308 | WITHDRAWN | Prostate Cancer |
New Mexico Cancer Research Alliance |
2011-06 | PHASE2 |
| NCT00508040 | COMPLETED | Birdshot Chorioretinopathy; Cystoid Macular Edema; Transient Partial Visual Loss |
Assistance Publique - Hôpitaux de Paris |
2007-09 | PHASE2 |
| NCT00485303 | COMPLETED | Prostatic Neoplasms; Prostate Cancer |
Cougar Biotechnology, Inc. |
2007-06 | PHASE2 |
| NCT00006721 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2001-03 | PHASE3 |
| NCT00002766 | COMPLETED | Leukemia; Lymphoma |
Memorial Sloan Kettering Cancer Center |
1996-03 | PHASE3 |
| NCT00789997 | COMPLETED | COPD Exacerbation |
Ottawa Hospital Research Institute |
2008-11 | PHASE2; PHASE3 |
| NCT00539838 | TERMINATED | Systemic Lupus Erythematosus |
Genentech, Inc. |
2007-12-19 | PHASE3 |
| NCT01042145 | COMPLETED | Croup |
Washington University School of Medicine |
2009-10 | PHASE4 |
| NCT00323960 | COMPLETED | Juvenile Dermatomyositis |
Istituto Giannina Gaslini |
2006-05-31 | PHASE3 |
| NCT00627354 | COMPLETED | Prostate Cancer |
Groupe D'Etude des Tumeurs Uro-Genitales |
2006-09 | PHASE2 |
| NCT00983944 | WITHDRAWN | Lymphoma |
Ohio State University Comprehensive Cancer Center |
2009-09 | PHASE2 |
| NCT00562965 | TERMINATED | Lymphoma, Follicular |
Pfizer |
2007-11 | PHASE3 |
| NCT00313781 | COMPLETED | Prostatic Neoplasms |
Pfizer |
2006-05 | PHASE2 |
| NCT00088881 | TERMINATED | Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2004-12 | PHASE2 |
| NCT00634647 | COMPLETED | Prostate Cancer; Genetic Polymorphism |
National Cancer Institute (NCI) |
2008-02-19 | PHASE2 |
| NCT00853411 | WITHDRAWN | Asthma |
University of Pittsburgh |
2008-12 | |
| NCT00801463 | COMPLETED | Proteinuria; Focal Segmental Glomerulosclerosis |
Nanjing University School of Medicine |
2009-01 | |
| NCT00306670 | TERMINATED | Hemophilia A |
Georgetown University |
2006-04 | PHASE2; PHASE3 |
| NCT00907452 | COMPLETED | Myeloma |
Intergroupe Francophone du Myelome |
2009-07-29 | |
| NCT00227591 | COMPLETED | Essential Thrombocythemia; Polycythemia Vera; Primary Myelofibrosis |
National Cancer Institute (NCI) |
2005-12 | PHASE2 |
| NCT00580229 | COMPLETED | Rheumatoid Arthritis |
University of South Florida |
2007-12 | PHASE2; PHASE3 |
| NCT00283712 | COMPLETED | Pemphigus |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-03 | PHASE2 |
| NCT01199029 | COMPLETED | Healthy |
Pfizer |
2010-08 | PHASE1 |
| NCT00430677 | TERMINATED | Systemic Lupus Erythematosus |
Bristol-Myers Squibb |
2007-06 | PHASE2; PHASE3 |
| NCT00598858 | WITHDRAWN | Prostate Cancer; Adenocarcinoma of the Prostate; Stage I Prostate Cancer; Stage II Prostate Cancer |
John P. Fruehauf |
2009-01 | PHASE2 |
| NCT01033864 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2009-11 | PHASE4 |
| NCT01017939 | COMPLETED | Prostate Neoplasms |
Janssen Research & Development, LLC |
2010-01 | PHASE1 |
| NCT00808418 | COMPLETED | Prostate Cancer |
Synta Pharmaceuticals Corp. |
2008-11 | PHASE1 |
| NCT00135499 | TERMINATED | Lymphoma, Large-Cell, Diffuse |
Lymphoma Study Association |
2001-10-16 | PHASE3 |
| NCT00514267 | COMPLETED | Prostate Cancer; Tumors |
Astellas Pharma Inc |
2007-05 | PHASE1; PHASE2 |
| NCT00278278 | UNKNOWN | Brain and Central Nervous System Tumors |
German Society for Pediatric Oncology and Hematology GPOH gGmbH |
2003-09 | PHASE3 |
| NCT00996502 | TERMINATED | Prostate Cancer |
Columbia University |
2006-07 | PHASE1; PHASE2 |
| NCT00751205 | COMPLETED | Prostate Cancer; Ovarian Cancer |
Bayer |
2008-08 | PHASE2 |
| NCT00399087 | COMPLETED | Neoplasms |
AEterna Zentaris |
2004-11 | PHASE1 |
| NCT00448734 | UNKNOWN | Hormone Refractory Prostate Cancer |
Poniard Pharmaceuticals |
2006-06 | PHASE1; PHASE2 |
| NCT00537381 | COMPLETED | Prostatic Neoplasms |
Centocor, Inc. |
2007-05 | PHASE2 |
| NCT00910754 | COMPLETED | Prostate Neoplasms |
Janssen Research & Development, LLC |
2009-05 | PHASE1 |
| NCT00369356 | COMPLETED | Coronary Artery Disease; Ischemic Heart Disease; Atherosclerosis |
Universita di Verona |
2006-10 | PHASE2; PHASE3 |
| NCT00097448 | COMPLETED | Sudden Deafness |
Massachusetts Eye and Ear Infirmary |
2004-12 | PHASE3 |
| NCT00623766 | COMPLETED | Melanoma |
Bristol-Myers Squibb |
2008-07 | PHASE2 |
| NCT00466440 | COMPLETED | Prostate Cancer |
Eli Lilly and Company |
2007-06 | PHASE2 |
| NCT00705822 | TERMINATED | Prostatic Neoplasms |
Sanofi |
2006-08 | PHASE3 |
| NCT00419926 | COMPLETED | Kidney Transplantation |
Novartis |
2006-12 | PHASE4 |
| NCT00551291 | COMPLETED | Myelodysplastic Syndromes |
Hoffmann-La Roche |
2007-08 | PHASE2 |
| NCT00203047 | TERMINATED | Relapsing Remitting Multiple Sclerosis |
Teva Branded Pharmaceutical Products R&D, Inc. |
2005-01 | PHASE4 |
| NCT00650078 | COMPLETED | Rheumatoid Arthritis |
Amgen |
2008-03 | PHASE3 |
| NCT00255606 | COMPLETED | Prostate Cancer |
Tampere University |
2005-08 | PHASE3 |
| NCT00494780 | COMPLETED | Lymphoma, Follicular |
GlaxoSmithKline |
2007-06 | PHASE2 |
| NCT00596947 | TERMINATED | Transplants and Implants |
University of Pennsylvania |
2005-10 | PHASE4 |
| NCT00413920 | COMPLETED | Renal Transplantation |
Novartis |
2007-04 | PHASE3 |
| NCT00119678 | COMPLETED | Systemic Lupus Erythematosus |
Bristol-Myers Squibb |
2005-09 | PHASE2 |
| NCT00089856 | TERMINATED | Prostate Cancer |
Cell Genesys |
2004-07 | PHASE3 |
| NCT00301821 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2006-01 | PHASE2 |
| NCT00377364 | COMPLETED | Asthma; Rheumatic Disease |
University of Texas Southwestern Medical Center |
2006-11 | PHASE4 |
| NCT00657774 | COMPLETED | Asthma |
SkyePharma AG |
2008-04 | PHASE1 |
| NCT00313482 | TERMINATED | Hormone Refractory Prostate Cancer |
Veeda Oncology |
2006-04 | PHASE2 |
| NCT00133224 | TERMINATED | Prostate Cancer |
Cell Genesys |
2005-07 | PHASE3 |
| NCT00136084 | COMPLETED | Leukemia, Myelocytic, Acute |
St. Jude Children's Research Hospital |
2002-08 | PHASE3 |
| NCT00452387 | TERMINATED | Metastatic Prostate Cancer |
Accelerated Community Oncology Research Network |
2007-05 | PHASE2 |
| NCT00486421 | COMPLETED | Nonneoplastic Condition |
Mayo Clinic |
2007-01 | EARLY_PHASE1 |
| NCT00961467 | COMPLETED | Multiple Myeloma |
Fondazione EMN Italy Onlus |
2007-02 | PHASE2 |
| NCT00597064 | UNKNOWN | Asthma |
Federal University of São Paulo |
2006-07 | PHASE4 |
| NCT00774202 | COMPLETED | Immune Thrombocytopenic Purpura |
Weill Medical College of Cornell University |
2003-11 | PHASE2; PHASE3 |
| NCT00374231 | COMPLETED | Liver Transplantation |
University of Cincinnati |
2002-10 | PHASE4 |
| NCT00110669 | COMPLETED | Duchenne Muscular Dystrophy |
Cooperative International Neuromuscular Research Group |
2004-01 | PHASE3 |
| NCT00337987 | COMPLETED | Peripheral T-Cell Lymphoma |
Yale University |
2005-11 | PHASE2 |
| NCT00275535 | COMPLETED | Kidney Diseases |
Mayo Clinic |
2001-04 | PHASE4 |
| NCT00161239 | TERMINATED | T-Cell Lymphoma |
University of Medicine and Dentistry of New Jersey |
2005-02 | |
| NCT00280098 | COMPLETED | Prostatic Neoplasms |
Sanofi |
2006-01 | PHASE4 |
| NCT00262405 | COMPLETED | Idiopathic Pulmonary Fibrosis |
University of Michigan |
2001-01 | PHASE2 |
| NCT00002565 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
1994-05-25 | PHASE3 |
| NCT00002463 | COMPLETED | Brain and Central Nervous System Tumors |
M.D. Anderson Cancer Center |
1989-02 | PHASE2 |
| NCT00053768 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2002-04 | PHASE3 |
| NCT00020943 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2001-06 | PHASE2 |
| NCT00041327 | COMPLETED | Lymphoma |
AIDS Malignancy Consortium |
2002-10 | PHASE2 |
| NCT00410657 | COMPLETED | Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell Tumor |
Fred Hutchinson Cancer Center |
2006-07 | PHASE2 |
| NCT00141037 | COMPLETED | Kidney Diseases; Kidney Transplantation; Kidney Transplant; Renal Transplantation; Renal Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2004-03 | PHASE1; PHASE2 |
| NCT00087165 | COMPLETED | Prostate Cancer |
University Health Network, Toronto |
2005-01 | PHASE2 |
| NCT00004231 | COMPLETED | Lymphoma |
Northwestern University |
1999-10 | PHASE2 |
| NCT00049569 | COMPLETED | L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Non-T, Non-B Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2003-01 | |
| NCT00268710 | COMPLETED | Prostatic Neoplasms |
Sanofi |
2004-02 | PHASE2 |
| NCT02767089 | COMPLETED | Healthy Adults |
Pfizer |
2005-10 | PHASE1 |
| NCT00309881 | COMPLETED | Chronic Lymphocytic Leukemia |
German CLL Study Group |
2003-04 | PHASE2 |
| NCT01225874 | COMPLETED | Leukemia |
Children's Oncology Group |
1999-12 | |
| NCT00228020 | COMPLETED | Pediatric Kidney Transplantation |
Novartis |
2001-05 | PHASE3 |
| NCT00656266 | TERMINATED | End-stage Liver Disease; Renal Insufficiency; Renal Failure |
Baylor College of Medicine |
2004-11 | PHASE4 |
| NCT00004482 | COMPLETED | Myocarditis; Giant Cell Myocarditis |
Mayo Clinic |
1999-12 | PHASE2 |
| NCT00032019 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2002-02 | PHASE2 |
| NCT00023231 | COMPLETED | End-Stage Renal Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2001-02 | |
| NCT00187122 | COMPLETED | Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
1993-03 | |
| NCT00002494 | COMPLETED | Leukemia; Lymphoma |
Alliance for Clinical Trials in Oncology |
1992-05 | PHASE2 |
| NCT00002700 | COMPLETED | Leukemia; Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1995-08 | PHASE3 |
| NCT00002657 | COMPLETED | Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm |
SWOG Cancer Research Network |
1995-05 | PHASE2 |
| NCT00002757 | COMPLETED | Leukemia; Lymphoma |
Children's Oncology Group |
2001-06 | PHASE3 |
| NCT00004010 | COMPLETED | Lymphoma |
Children's Oncology Group |
1999-10 | PHASE2 |
| NCT00002548 | COMPLETED | Multiple Myeloma |
SWOG Cancer Research Network |
1994-01 | PHASE3 |
| NCT00006054 | TERMINATED | Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; X-linked Agammaglobulinemia; Wiskott-Aldrich Syndrome; Chronic Granulomatous Disease; X-linked Hyper IgM Syndrome; Severe Combined Immunodeficiency; Leukocyte Adhesion Deficiency Syndrome; Virus-Associated Hemophagocytic Syndrome |
Fairview University Medical Center |
2000-03 | |
| NCT00187005 | TERMINATED | Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
1998-07 | PHASE3 |
| NCT00006890 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
NCIC Clinical Trials Group |
2000-07-12 | PHASE2 |
| NCT00002665 | COMPLETED | Leukemia; Neutropenia; Thrombocytopenia |
SWOG Cancer Research Network |
1995-07 | PHASE2 |
| NCT00002618 | COMPLETED | Lymphoma |
Children's Oncology Group |
1994-12 | PHASE3 |
| NCT00002462 | ACTIVE_NOT_RECRUITING | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1989-09 | PHASE3 |
| NCT00006669 | WITHDRAWN | Lymphoma |
Medstar Health Research Institute |
1999-09 | PHASE2 |
| NCT00004039 | WITHDRAWN | Lymphoma |
Hoag Memorial Hospital Presbyterian |
1998-06 | PHASE2 |
| NCT00379041 | ACTIVE_NOT_RECRUITING | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1993-09-01 | PHASE3 |
| NCT00080925 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
National Institutes of Health Clinical Center (CC) |
2004-02 | PHASE1 |
| NCT00002653 | UNKNOWN | Multiple Myeloma and Plasma Cell Neoplasm |
Medical Research Council |
1993-09 | PHASE3 |
| NCT00004646 | COMPLETED | Duchenne Muscular Dystrophy |
National Center for Research Resources (NCRR) |
1995-04 | PHASE3 |
| NCT00014339 | UNKNOWN | Multiple Myeloma and Plasma Cell Neoplasm |
Medsearch |
2000-03 | PHASE3 |
| NCT00561106 | COMPLETED | Bell´s Palsy |
Universidad de la Republica |
2002-12 | |
| NCT00003578 | UNKNOWN | Lymphoma |
Lymphoma Trials Office |
1993-01 | PHASE3 |
| NCT00041210 | UNKNOWN | Lymphoma |
Mount Vernon Cancer Centre at Mount Vernon Hospital |
2001-10 | PHASE3 |
| NCT00028717 | UNKNOWN | Lymphoma |
Commissie Voor Klinisch Toegepast Onderzoek |
2001-02 | PHASE3 |
| NCT00811031 | WITHDRAWN | Prostate Cancer |
M.D. Anderson Cancer Center |
PHASE2 | |
| NCT00195429 | COMPLETED | Kidney Failure; Graft vs Host Disease |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-08 | PHASE4 |
| NCT00556127 | COMPLETED | Diffuse Large B-Cell Lymphoma; POOR PROGNOSIS |
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie |
2002-06 | PHASE2 |
| NCT00307645 | TERMINATED | ANCA Associated Systemic Vasculitis Including Wegener's; Granulomatosis and Microscopic Polyangiitis and; Renal Limited Vasculitis |
Assistance Publique - Hôpitaux de Paris |
2003-05 | PHASE3 |
| NCT00070447 | COMPLETED | Lymphoma |
National Cancer Institute (NCI) |
2003-11 | PHASE2 |
| NCT00518310 | UNKNOWN | Idiopathic Pulmonary Fibrosis |
Thorax National Institute |
2005-05 | |
| NCT00268567 | COMPLETED | Nephritis, Lupus |
Peking University |
2002-10 | PHASE2; PHASE3 |
| NCT00336414 | WITHDRAWN | Systemic Lupus Erythematosus Nephritis |
Istituto Giannina Gaslini |
2006-06 | PHASE3 |
| NCT00358020 | COMPLETED | Multiple Myeloma |
University of Turin, Italy |
2004-11 | PHASE2 |
| NCT00000819 | COMPLETED | HIV Infections; AIDS-Associated Nephropathy |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00005959 | UNKNOWN | Lymphoma |
Amgen |
1999-12 | PHASE2 |
| NCT00022945 | COMPLETED | Mantle Cell Lymphoma |
Corixa Corporation |
PHASE2 | |
| NCT00002499 | UNKNOWN | Leukemia |
Grupo Argentino de Tratamiento de la Leucemia Aguda |
1990-01 | PHASE2; PHASE3 |
| NCT00018954 | COMPLETED | Leukemia; Lymphoma |
National Institutes of Health Clinical Center (CC) |
1992-10 | PHASE2 |
(data from https://clinicaltrials.gov, updated on 2026-06-11)
Check the
Prednisone
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Note: Technical data last updated: Sep 1, 2026.